Cargando…
Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)
AIM: To evaluate the overall health and functioning in patients with axial spondyloarthritis (axSpA) and related factors affecting these during the COVID-19 pandemic and lockdown measures. METHODS: Data from 587 axSpA patients participating in the first phase (April–July 2020) of the REUMAVID study...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777346/ https://www.ncbi.nlm.nih.gov/pubmed/35069810 http://dx.doi.org/10.1177/1759720X211066685 |
_version_ | 1784637049826967552 |
---|---|
author | Benavent, Diego Garrido-Cumbrera, Marco Plasencia-Rodríguez, Chamaida Marzo-Ortega, Helena Christen, Laura Correa-Fernández, José Plazuelo-Ramos, Pedro Webb, Dale Navarro-Compán, Victoria |
author_facet | Benavent, Diego Garrido-Cumbrera, Marco Plasencia-Rodríguez, Chamaida Marzo-Ortega, Helena Christen, Laura Correa-Fernández, José Plazuelo-Ramos, Pedro Webb, Dale Navarro-Compán, Victoria |
author_sort | Benavent, Diego |
collection | PubMed |
description | AIM: To evaluate the overall health and functioning in patients with axial spondyloarthritis (axSpA) and related factors affecting these during the COVID-19 pandemic and lockdown measures. METHODS: Data from 587 axSpA patients participating in the first phase (April–July 2020) of the REUMAVID study who completed the ASAS Health Index (ASAS-HI) were analysed. REUMAVID is a cross-sectional study that collects data through an online survey to assess the impact of the COVID-19 pandemic on patients with rheumatic and musculoskeletal diseases across seven European countries. Poor health was defined as ASAS-HI ⩾ 12. The World Health Organization Five well-being index, self-perceived health status and change in health status during COVID-19 pandemic were evaluated as secondary outcomes. Logistic regression models were used to identify the factors associated with poor health. RESULTS: According to the ASAS-HI, 147 (25.0%) patients reported poor health. Pain and moving around were the main affected categories. In addition, 14.0% reported their self-perceived health status as ‘bad’ or ‘very bad’ and 46.8% as worse than before the pandemic. In the multivariate analysis, smoking (OR = 1.98), diabetes (OR = 4.89) and taking painkillers (OR = 2.82) or corticosteroids use (OR = 2.20) were significantly associated with poor health, while engaging in physical activity (OR = 0.54) and being actively employed (OR = 0.48) were inversely associated with this. CONCLUSIONS: During the first wave of the COVID-19 pandemic, one in four axSpA patients reported poor health and functioning, while the self-perceived health status of almost half of these patients worsened. Nonsmoking, physical activity and being employed were associated with better outcomes. |
format | Online Article Text |
id | pubmed-8777346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-87773462022-01-22 Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1) Benavent, Diego Garrido-Cumbrera, Marco Plasencia-Rodríguez, Chamaida Marzo-Ortega, Helena Christen, Laura Correa-Fernández, José Plazuelo-Ramos, Pedro Webb, Dale Navarro-Compán, Victoria Ther Adv Musculoskelet Dis Original Research AIM: To evaluate the overall health and functioning in patients with axial spondyloarthritis (axSpA) and related factors affecting these during the COVID-19 pandemic and lockdown measures. METHODS: Data from 587 axSpA patients participating in the first phase (April–July 2020) of the REUMAVID study who completed the ASAS Health Index (ASAS-HI) were analysed. REUMAVID is a cross-sectional study that collects data through an online survey to assess the impact of the COVID-19 pandemic on patients with rheumatic and musculoskeletal diseases across seven European countries. Poor health was defined as ASAS-HI ⩾ 12. The World Health Organization Five well-being index, self-perceived health status and change in health status during COVID-19 pandemic were evaluated as secondary outcomes. Logistic regression models were used to identify the factors associated with poor health. RESULTS: According to the ASAS-HI, 147 (25.0%) patients reported poor health. Pain and moving around were the main affected categories. In addition, 14.0% reported their self-perceived health status as ‘bad’ or ‘very bad’ and 46.8% as worse than before the pandemic. In the multivariate analysis, smoking (OR = 1.98), diabetes (OR = 4.89) and taking painkillers (OR = 2.82) or corticosteroids use (OR = 2.20) were significantly associated with poor health, while engaging in physical activity (OR = 0.54) and being actively employed (OR = 0.48) were inversely associated with this. CONCLUSIONS: During the first wave of the COVID-19 pandemic, one in four axSpA patients reported poor health and functioning, while the self-perceived health status of almost half of these patients worsened. Nonsmoking, physical activity and being employed were associated with better outcomes. SAGE Publications 2022-01-19 /pmc/articles/PMC8777346/ /pubmed/35069810 http://dx.doi.org/10.1177/1759720X211066685 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Benavent, Diego Garrido-Cumbrera, Marco Plasencia-Rodríguez, Chamaida Marzo-Ortega, Helena Christen, Laura Correa-Fernández, José Plazuelo-Ramos, Pedro Webb, Dale Navarro-Compán, Victoria Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1) |
title | Poor health and functioning in patients with axial spondyloarthritis
during the COVID-19 pandemic and lockdown: REUMAVID study (phase
1) |
title_full | Poor health and functioning in patients with axial spondyloarthritis
during the COVID-19 pandemic and lockdown: REUMAVID study (phase
1) |
title_fullStr | Poor health and functioning in patients with axial spondyloarthritis
during the COVID-19 pandemic and lockdown: REUMAVID study (phase
1) |
title_full_unstemmed | Poor health and functioning in patients with axial spondyloarthritis
during the COVID-19 pandemic and lockdown: REUMAVID study (phase
1) |
title_short | Poor health and functioning in patients with axial spondyloarthritis
during the COVID-19 pandemic and lockdown: REUMAVID study (phase
1) |
title_sort | poor health and functioning in patients with axial spondyloarthritis
during the covid-19 pandemic and lockdown: reumavid study (phase
1) |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777346/ https://www.ncbi.nlm.nih.gov/pubmed/35069810 http://dx.doi.org/10.1177/1759720X211066685 |
work_keys_str_mv | AT benaventdiego poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1 AT garridocumbreramarco poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1 AT plasenciarodriguezchamaida poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1 AT marzoortegahelena poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1 AT christenlaura poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1 AT correafernandezjose poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1 AT plazueloramospedro poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1 AT webbdale poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1 AT navarrocompanvictoria poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1 |